Arch Iran Med. 2021;24(5): 354-363. doi: 10.34172/aim.2021.52

Original Article

Efficacy and Safety of Tofacitinib for Treatment of Moderate to Severe Active Ulcerative Colitis: First Report from Iran

Maryam Jameshorani 1, Homayoon Vahedi 2, Anahita Sadeghi 2, Ali Reza Sima 2, Amir Anushiravani 2, Helia Nateghi beige 2, Masoud M. Malekzadeh 2, Shokoofeh Naserinejad 2, Sudabeh Alatab 2 *

Cited by CrossRef:


Since we have many accepted case reports, we are not able to evaluate new ones until the first of January 2022.

AIM Editorial Office

SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.